Management of Chronic Dyspepsia

Clinical Assessment and Risk Stratification

The British Society of Gastroenterology recommends endoscopy only for patients ≥40 years from areas at increased risk of gastric cancer OR with family history of gastric/esophageal cancer 1
The age threshold for urgent endoscopy is typically ≥40 years for high-risk populations or ≥55 years for average-risk populations 1
BMI 35 (obesity) is not an alarm feature and does not mandate endoscopy 1
No palpable abdominal mass is present in this patient 1

For low-risk patients with dyspepsia lasting ≥4 weeks without alarm symptoms, test for H. pylori infection and treat if positive 5, 1
This strategy is cost-effective and safe provided appropriate follow-up is organized 5
Eradication of H. pylori eliminates the risk of peptic ulcer mortality, even though many patients may have residual functional symptoms 5
If H. pylori negative or symptoms persist after eradication, initiate full-dose PPI therapy (omeprazole 20-40 mg once daily before meals) for ulcer-like dyspepsia with epigastric pain worsened by meals 5, 2, 4
Healing rates are 80-90% for duodenal ulcers and 70-80% for gastric ulcers with PPI therapy 2, 4

Always exclude myocardial ischemia in patients with epigastric pain, especially with risk factors (obesity in this case), as MI can present atypically with mortality rates of 10-20% if missed 2, 3
Organize systematic follow-up after initiating test-and-treat strategy to ensure symptom resolution and identify patients requiring escalation to endoscopy 5, 1
Approximately 10% of patients with dyspepsia have peptic ulcer disease, and H. pylori eradication prevents ulcer-related mortality 5, 2